tmk oper ep y/i larg consist estim
consensu life sale increas y/i slightli
outlook net sale growth exceed project tmk
modestli rais oper ep guidanc
midpoint tmk updat ep guidanc reflect increas previou
guidanc impli y/i ep growth includ boost tax reform tmk also
repurchas share mostli in-lin estim
life underwrit incom grew y/i slightli outlook
life underwrit margin better year ago project
life net sale growth y/i slightli estim notabl
tmk anticip life direct respons direct-to-consum distribut channel
sale return growth point refer life direct respons sale
declin also expect declin
respons elev claim experi
underwrit incom y/i better outlook
underwrit margin estim year
ago net sale increas y/i better outlook
slightli lower ep take updat guidanc
account chang estim tmk strong franchis middle-
market life supplement health insur us howev dont see much
upsid ep expect next year result slow premium
growth stabl margin view tmk overvalu ep estim
book valu ex-aoci rel roe profil
tmk quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
underweight torchmark strong franchis
middle-market life supplement health
insur us howev see much
upsid ep expect next year
result slow premium growth stabl
tmk averag roe strong earn
growth low volatil view tmk upsid
scenario base ep
risk thesi includ slower-than-anticip
econom recoveri impact low interest rate
regulatori risk view tmk downsid case
ep
continu next page
mil except per shry/i underwrit margin excess invest incom ep valu ex aoci chg mil except per shry/i sale ex part sale chg barclay torchmark corp
mil except per polici acquisit segment underwrit invest requir interest net polici interest excess invest compani oper oper incom stock compens compens expens net oper incom continu oper uilic medicar part d- net oper incom gain loss capit gain loss discontinu ops- loss dispos discontinu ops- part adjustment- tax settlements- net sharenet oper incom continu oper incom dilut share per ratio total benefit oper profit oper profit percent excess invest oper earn continu op ep continu valu per common valu per share ex unreal inv gains/ loss qtr chang book valu per share ex unreal return return equiti return equiti ex unreal tax capit exclud reval invest portfolio yield share amt share amt common capit capit return normal annual barclay torchmark corp
jay gelb cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
